What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Immune system
- Antibody
His scientific interests lie mostly in Immunology, Common variable immunodeficiency, Internal medicine, Hypogammaglobulinemia and B cell.
His work in Antibody, Antigen, Immune system, B-1 cell and Lymphocyte are all subfields of Immunology research.
Hans-Hartmut Peter interconnects Allele and Loss of heterozygosity in the investigation of issues within Antibody.
His Common variable immunodeficiency research includes elements of Immunodeficiency, Autoimmune hemolytic anemia, Autoimmune Cytopenia, Germinal center and Primary immunodeficiency.
His Internal medicine research integrates issues from Endocrinology, Surgery and CD40.
The various areas that Hans-Hartmut Peter examines in his Surgery study include Gastroenterology and Severity of illness.
His most cited work include:
- Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. (567 citations)
- The EUROclass trial: defining subgroups in common variable immunodeficiency (565 citations)
- Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans (563 citations)
What are the main themes of his work throughout his whole career to date?
Hans-Hartmut Peter focuses on Immunology, Internal medicine, Common variable immunodeficiency, Antibody and Pathology.
His research related to Antigen, B cell, Rheumatoid arthritis, Immunodeficiency and Autoantibody might be considered part of Immunology.
His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology, Endocrinology and Surgery.
His biological study spans a wide range of topics, including Hypogammaglobulinemia and Immune system.
The concepts of his Antibody study are interwoven with issues in In vitro and Immunopathology.
His work carried out in the field of Pathology brings together such families of science as Positron emission tomography and Magnetic resonance imaging.
He most often published in these fields:
- Immunology (58.16%)
- Internal medicine (23.98%)
- Common variable immunodeficiency (18.37%)
What were the highlights of his more recent work (between 2007-2016)?
- Immunology (58.16%)
- Internal medicine (23.98%)
- Common variable immunodeficiency (18.37%)
In recent papers he was focusing on the following fields of study:
Hans-Hartmut Peter mainly focuses on Immunology, Internal medicine, Common variable immunodeficiency, Abatacept and Antibody.
His work is connected to B cell, Hypogammaglobulinemia, B-1 cell, Immunodeficiency and Primary immunodeficiency, as a part of Immunology.
His research integrates issues of Gastroenterology, Magnetic resonance imaging and Surgery in his study of Internal medicine.
His study in Common variable immunodeficiency is interdisciplinary in nature, drawing from both T-cell homeostasis, Cytopenia, Autoimmune Cytopenia and Compartment.
In Abatacept, Hans-Hartmut Peter works on issues like Rheumatoid arthritis, which are connected to Physical therapy, Erythrocyte sedimentation rate, Confidence interval and Clinical endpoint.
His Antibody research incorporates elements of Sequence alignment, Chronic disease and Systemic vasculitis.
Between 2007 and 2016, his most popular works were:
- The EUROclass trial: defining subgroups in common variable immunodeficiency (565 citations)
- B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans (269 citations)
- Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells (224 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Immune system
- Antibody
Hans-Hartmut Peter mainly investigates Immunology, Common variable immunodeficiency, Antibody, B cell and Hypogammaglobulinemia.
His studies in Common variable immunodeficiency integrate themes in fields like Inflammatory bowel disease, Internal medicine, Cytopenia, Autoimmune Cytopenia and Primary immunodeficiency.
Hans-Hartmut Peter has researched Internal medicine in several fields, including Gamma globulin and Immunoglobulin G.
The study incorporates disciplines such as Chronic disease and Systemic vasculitis in addition to Antibody.
The B cell study combines topics in areas such as Calcium, Intracellular, Calcium flux and Calcium signaling.
His Hypogammaglobulinemia research incorporates themes from Heterozygote advantage, Allele, Genotype, Loss of heterozygosity and Immunoglobulin D.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
